34 related articles for article (PubMed ID: 9056749)
1. Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors.
Jablonka F; Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
Sao Paulo Med J; 2009 Jan; 127(1):19-22. PubMed ID: 19466290
[TBL] [Abstract][Full Text] [Related]
2. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction.
Giannobile WV
Ann N Y Acad Sci; 1999 Jun; 878():404-12. PubMed ID: 10415744
[TBL] [Abstract][Full Text] [Related]
3. Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis.
Song MK; Park SI; Cho SW
J Bone Miner Metab; 2023 May; 41(3):337-344. PubMed ID: 36729305
[TBL] [Abstract][Full Text] [Related]
4. Bone Turnover Markers: Basic Biology to Clinical Applications.
Schini M; Vilaca T; Gossiel F; Salam S; Eastell R
Endocr Rev; 2023 May; 44(3):417-473. PubMed ID: 36510335
[TBL] [Abstract][Full Text] [Related]
5. Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE.
Santini D; Cinieri S; Gasparro D; Bordonaro R; Guglielmini PF; Chiuri VE; D'Angelillo RM; Ceresoli GL; Fagnani D; Acquati M; Mencoboni M; Lanzetta G; Sartori D; Carlini P; Panebianco F; Beccaglia P; Procopio G
J Bone Oncol; 2021 Feb; 26():100341. PubMed ID: 33425672
[TBL] [Abstract][Full Text] [Related]
6. Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases.
Wood SL; Brown JE
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751181
[TBL] [Abstract][Full Text] [Related]
7. The role of biomarkers in the management of bone-homing malignancies.
D'Oronzo S; Brown J; Coleman R
J Bone Oncol; 2017 Nov; 9():1-9. PubMed ID: 28948139
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
Takahashi S
Clin Calcium; 2006 Apr; 16(4):581- 90. PubMed ID: 16582508
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of bone collagen type I metabolism.
Zaitseva OV; Shandrenko SG; Veliky MM
Ukr Biochem J; 2015; 87(1):21-32. PubMed ID: 26036128
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of some biochemical bone markers for the detection of bone metastases in prostate cancer.
Westerhuis LW; Delaere KP
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):89-94. PubMed ID: 9056749
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
12. Collagen derived serum markers in carcinoma of the prostate.
Rudnicki M; Jensen LT; Iversen P
Scand J Urol Nephrol; 1995 Sep; 29(3):317-21. PubMed ID: 8578275
[TBL] [Abstract][Full Text] [Related]
13. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
[TBL] [Abstract][Full Text] [Related]
14. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Noguchi M; Noda S
J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
[TBL] [Abstract][Full Text] [Related]
15. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
